1995
DOI: 10.1128/jcm.33.8.2036-2041.1995
|View full text |Cite
|
Sign up to set email alerts
|

Detection of human immunodeficiency virus type 1 proviral DNA by PCR using an electrochemiluminescence-tagged probe

Abstract: We have developed a rapid, pseudohomogeneous assay for the detection of PCR amplicons, based on the use of electrochemiluminescence generated from a Tris-bipyridine ruthenium(II) label. PCR amplification of highly conserved human immunodeficiency virus type 1 (HIV-1) gag gene sequences was performed with SK38 and SK39 primers, the latter of which was 5 biotinylated. Post-PCR reaction mixtures were combined with 10 12 copies of the SK19 probe-Tris-bipyridine ruthenium(II) conjugate, denatured by heating at 100 … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
14
0

Year Published

1997
1997
2018
2018

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 31 publications
(14 citation statements)
references
References 21 publications
0
14
0
Order By: Relevance
“…Typically, these involve the hybridization and labeling of specific nucleic acid sequences to test for disease states, predisposition for a disease and infectious diseases. Assays for a variety of analytes have been reported in the areas of infectious diseases, [353][354][355][356][357][358][359][360][361][362][363][364][365][366][367][368][369][370] tumor markers, [371][372][373][374] metabolism, 375 venous thromboembolism, 376 and cystic fibrosis 377 (Table S6, ESIw). Several studies have coupled ECL with polymerase chain reaction (PCR) amplification to lower detection limits and increase sensitivity.…”
Section: Clinical Applicationsmentioning
confidence: 99%
“…Typically, these involve the hybridization and labeling of specific nucleic acid sequences to test for disease states, predisposition for a disease and infectious diseases. Assays for a variety of analytes have been reported in the areas of infectious diseases, [353][354][355][356][357][358][359][360][361][362][363][364][365][366][367][368][369][370] tumor markers, [371][372][373][374] metabolism, 375 venous thromboembolism, 376 and cystic fibrosis 377 (Table S6, ESIw). Several studies have coupled ECL with polymerase chain reaction (PCR) amplification to lower detection limits and increase sensitivity.…”
Section: Clinical Applicationsmentioning
confidence: 99%
“…Electrochemiluminescent detection of the HIV-1 specific amplification products were measured as described by Schutzbank and Smith [39]. Briefly, cells were removed and suspended in 250 l of lysis buffer (50 mM KCl, 10 mM Tris-HCl, pH 8.3, 2.5 mM MgCl, 0.45% Nonidet P-40, 0.45% Tween 20, and 10 g/ml proteinase K).…”
Section: Detection Of Proviral Dna By Polymerase Chain Reactionmentioning
confidence: 99%
“…In the performance of sequence-specific DNA detection, polymerase chain reaction (PCR) is studied and employed most widely owing to its high sensitivity of fewer than five copies (even one copy) and many other advantages. 1,2 The technology of detecting PCR products is advancing the development of the whole kit to be more and more satisfactory. To date, the realtime PCR that employs fluorescent probes has established itself as the state-of-the-art technology.…”
Section: Introductionmentioning
confidence: 99%